Search
for
Sort by
Research 181–210 of 1000+
- Dermatologic Adverse Events from Cancer Treatments
- Hair and nail adverse events during treatment with target therapies for metastatic melanoma
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- Targeted delivery of siRNA to human cancer and human embryonic stem cells with cell level resolution
- Hair disorders in patients with cancer
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- Abstract P5-09-21: Selective androgen receptor modulators (SARMs): Enobosarm as targeted therapy for the treatment of androgen receptor-positive breast cancer
- Management of Alopecia Due to Cancer Therapies
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Cellular senescence in skin‐related research: Targeted signaling pathways and naturally occurring therapeutic agents
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- B/N-doped carbon nano-onions as nanocarriers for targeted breast cancer therapy
- Assessing the cost-effectiveness of DNA origami nanostructures for targeted delivery of anti-cancer drugs to tumours
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- An Update on Drug-Induced Pigmentation
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Signaling Involved in Hair Follicle Morphogenesis and Development
- Novel Therapeutic Hybrid Systems Using Hydrogels and Nanotechnology: A Focus on Nanoemulgels for the Treatment of Skin Diseases